T helper cytokines in dry eye disease

Experimental Eye Research

Volumn 117, Issue , 2013, Pages 118-125

  Pflugfelder, Stephen C ^a   Corrales, Rosa M ^a   de Paiva, Cintia S ^a  

^a CULLEN EYE INSTITUTE   (United States)

Author keywords

Cytokine; Dry eye; Inflammation; Interferon gamma; Interleukin 13; Interleukin 17; T cell; Tear dysfunction

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 4;

APOPTOSIS; CELL DIFFERENTIATION; CELL MIGRATION; CONJUNCTIVA EPITHELIUM; DRY EYE; EPITHELIUM CELL; GOBLET CELL; HELPER CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL METAPLASIA; TH1 CELL; TH17 CELL;

CYTOKINE; DRY EYE; INFLAMMATION; INTERFERON GAMMA; INTERLEUKIN 13; INTERLEUKIN 17; T CELL; TEAR DYSFUNCTION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; DRY EYE SYNDROMES; HUMANS; MICE; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS;

EID: 84888136774     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.08.013     Document Type: Review

References (153)

1. Aggarwal S., Gurney A.L. IL-17: prototype member of an emerging cytokine family. J.Leukoc. Biol. 2002, 71:1-8.
2. Ajjan R.A., McIntosh R.S., Waterman E.A., Watson P.F., Franklin C.D., Yeoman C.M., Weetman A.P. Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjogren's syndrome. Br. J. Rheumatol. 1998, 37:179-185.
3. Akdis M., Palomares O., van D.V., van S.M., Akdis C.A. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J.Allergy Clin. Immunol. 2012, 129:1438-1449.
4. Albertsmeyer A.C., Kakkassery V., Spurr-Michaud S., Beeks O., Gipson I.K. Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp. Eye Res. 2010, 90:444-451.
5. Andolfi G., Fousteri G., Rossetti M., Magnani C.F., Jofra T., Locafaro G., Bondanza A., Gregori S., Roncarolo M.G. Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells. Mol. Ther. 2012, 20:1778-1790.
6. + Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene. Mol. Immunol. 2012, 51:143-149.
7. Battaglia M., Gregori S., Bacchetta R., Roncarolo M.G. Tr1 cells: from discovery to their clinical application. Semin. Immunol. 2006, 18:120-127.
8. Baudouin C., Brignole F., Pisella P.J., De Jean M.S., Goguel A. Flow cytometric analysis of the inflammatory marker HLA DR in dry eye syndrome: results from 12 months of randomized treatment with topical cyclosporin A. Adv. Exp. Med. Biol. 2002, 506:761-769.
9. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
10. Bettelli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007, 8:345-350.
11. Boehm N., Riechardt A.I., Wiegand M., Pfeiffer N., Grus F.H. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Investig. Ophthalmol. Vis. Sci. 2011, 52:7725-7730.
12. Brignole F., Pisella P.J., De Saint J.M., Goldschild M., Goguel A., Baudouin C. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Investig. Ophthalmol. Vis. Sci. 2001, 42:90-95.
13. Brignole F., Pisella P.J., Goldschild M., De Saint J.M., Goguel A., Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Investig. Ophthalmol. Vis. Sci. 2000, 41:1356-1363.
14. Brookes S.M., Price E.J., Venables P.J., Maini R.N. Interferon-gamma and epithelial cell activation in Sjogren's syndrome. Br. J. Rheumatol. 1995, 34:226-231.
15. Calonge M. The treatment of dry eye. Surv. Ophthalmol. 2001, 45(Suppl.2):S227-S239.
16. Carreno E., Enriquez-de-Salamanca A., Teson M., Garcia-Vazquez C., Stern M.E., Whitcup S.M., Calonge M. Cytokine and chemokine levels in tears from healthy subjects. Acta Ophthalmol. 2010, 88:e250-e258.
17. Carrier Y., Yuan J., Kuchroo V.K., Weiner H.L. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J.Immunol. 2007, 178:179-185.
18. Carrier Y., Yuan J., Kuchroo V.K., Weiner H.L. Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity. J.Immunol. 2007, 178:172-178.
19. Cha S., Brayer J., Gao J., Brown V., Killedar S., Yasunari U., Peck A.B. Adual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 2004, 60:552-565.
20. Chauhan S.K., El A.J., Ecoiffier T., Goyal S., Zhang Q., Saban D.R., Dana R. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J.Immunol. 2009, 182:1247-1252.
21. Chauhan S.K., Jin Y., Goyal S., Lee H.S., Fuchsluger T.A., Lee H.K., Dana R. Anovel pro-lymphangiogenic function for Th17/IL-17. Blood 2011, 118(17):4630-4634.
22. Chen G., Korfhagen T.R., Xu Y., Kitzmiller J., Wert S.E., Maeda Y., Gregorieff Clevers A.H., Whitsett J.A. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J.Clin. Investig. 2009, 119:2914-2924.
23. Chen Y., Chauhan S.K., Saban D.R., Sadrai Z., Okanobo A., Dana R. Interferon-{gamma}-secreting NK cells promote induction of dry eye disease. J.Leukoc. Biol. 2011, 89:965-972.
24. Chen Y., Chauhan S.K., Soo Lee H., Saban D.R., Dana R. Chronic dry eye disease is principally mediated by effector memory Th17 cells. Mucosal Immunol. 2013 Apr 10, (Epub ahead of print).
25. Chen Z., Mok H., Pflugfelder S.C., Li D.Q., Barry M.A. Improved transduction of human corneal epithelial progenitor cells with cell-targeting adenoviral vectors. Exp. Eye Res. 2006, 83:798-806.
26. Chen Z., O'Shea J.J. Th17 cells: a new fate for differentiating helper T cells. Immunol. Res. 2008, 41:87-102.
27. Clark D.A., Lamey P.J., Jarrett R.F., Onions D.E. Amodel to study viral and cytokine involvement in Sjogren's syndrome. Autoimmunity 1994, 18:7-14.
28. Cooke A. Th17 cells in inflammatory conditions. Rev. Diabet. Stud. 2006, 3:72-75.
29. Corrales R.M., Pflugfelder S.C. Regulators of MUC5AC gene expression in conjunctival epithelia of dry eye patients. Investig. Ophthalmol. Vis. Sci. 2013, 54. (ARVO E- 913).
30. Corrales R.M., Villarreal A., Farley W., Stern M.E., Li D.Q., Pflugfelder S.C. Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress. Cornea 2007, 26:579-584.
31. Coursey T.G., Gandhi N.B., Volpe E.A., Pflugfelder S.C., de Paiva C.S. CCR6 KO Mice Are Resistant to Dry Eye Disease 2012, 2324. (ARVO Meeting Abstracts March 53).
32. Dardalhon V., Korn T., Kuchroo V.K., Anderson A.C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J.Autoimmun. 2008, 31:252-256.
33. de Paiva C.S., Chotikavanich S., Pangelinan S.B., Pitcher J.I., Fang B., Zheng X., Ma P., Farley W.J., Siemasko K.S., Niederkorn J.Y., Stern M.E., Li D.-Q., Pflugfelder S.C. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. May 2009, 2(3):243-253. Epub 2009 Feb 25. (Epub ahead of print).
34. de Paiva C.S., Corrales R.M., Villarreal A.L., Farley W., Li D.Q., Stern M.E., Pflugfelder S.C. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Investig. Ophthalmol. Vis. Sci. 2006, 47:2847-2856.
35. de Paiva C.S., Hwang C.S., Pitcher J.D., Pangelinan S.B., Rahimy E., Chen W., Yoon K.C., Farley W.J., Niederkorn J.Y., Stern M.E., Li D.Q., Pflugfelder S.C. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) 2010, 49:246-258.
36. de Paiva C.S., Raince J.K., McClellan A.J., Shanmugam K.P., Pangelinan S.B., Volpe E.A., Corrales R.M., Farley W.J., Corry D.B., Li D.Q., Pflugfelder S.C. Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol. 2010, 4(4):397-408. (Epub 2010 Dec 22). 10.1038/mi.2010.82.
37. de Paiva C.S., Villarreal A.L., Corrales R.M., Rahman H.T., Chang V.Y., Farley W.J., Stern M.E., Niederkorn J.Y., Li D.Q., Pflugfelder S.C. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-{gamma}. Investig. Ophthalmol. Vis. Sci. 2007, 48:2553-2560.
38. de Paiva C.S., Volpe E.A., Gandhi N.B., Zhang X., Zheng X., Pitcher J.D., Farley W.J., Stern M.E., Niederkorn J.Y., Li D.Q., Flavell R.A., Pflugfelder S.C. Disruption of TGF-beta signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca. PLoS One 2011, 6:e29017. (Epub 2011 Dec 14).
39. De Saint J.M., Brignole F., Feldmann G., Goguel A., Baudouin C. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells. Investig. Ophthalmol. Vis. Sci. 1999, 40:2199-2212.
40. Doherty T., Broide D. Cytokines and growth factors in airway remodeling in asthma. Curr. Opin. Immunol. 2007, 19:676-680.
41. Dohlman T.H., Chauhan S.K., Kodati S., Hua J., Chen Y., Omoto M., Sadrai Z., Dana R. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Investig. Ophthalmol. Vis. Sci. 2013, 54:4081-4091.
42. Enriquez-de-Salamanca A., Castellanos E., Stern M.E., Fernandez I., Carreno E., Garcia-Vazquez C., Herreras J.M., Calonge M. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol. Vis. 2010, 16:862-873.
43. Ewert P., Aguilera S., Alliende C., Kwon Y.J., Albornoz A., Molina C., Urzua U., Quest A.F., Olea N., Perez P., Castro I., Barrera M.J., Romo R., Hermoso M., Leyton C., Gonzalez M.J. Disruption of tight junction structure in salivary glands from Sjogren's syndrome patients is linked to proinflammatory cytokine exposure. Arthritis Rheum. 2010, 62:1280-1289.
44. Eyerich S., Eyerich K., Pennino D., Carbone T., Nasorri F., Pallotta S., Cianfarani F., Odorisio T., Traidl-Hoffmann C., Behrendt H., Durham S.R., Schmidt-Weber C.B., Cavani A. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J.Clin. Investig. 2009, 119:3573-3585.
45. Giron-Gonzalez J.A., Baturone R., Soto M.J., Marquez M., Macias I., Montes de O.M., Medina F., Chozas N., Garcia-Perez S. Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjogren's syndrome. Cell. Immunol. 2009, 259:56-60.
46. Goyal S., Chauhan S.K., Zhang Q., Dana R. Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. Arch. Ophthalmol. 2009, 127:882-887.
47. Gregorieff A., Stange D.E., Kujala P., Begthel H., van den Born M., Korving J., Peters P.J., Clevers H. The ets-domain transcription factor Spdef promotes maturation of goblet and paneth cells in the intestinal epithelium. Gastroenterology 2009, 137:1333-1345.
48. Hagiwara E., Pando J., Ishigatsubo Y., Klinman D.M. Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjogren's syndrome. J.Rheumatol. 1998, 25:89-93.
49. Hattori T., Saban D.R., Emami-Naeini P., Chauhan S.K., Funaki T., Ueno H., Dana R. Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. J.Leukoc. Biol. 2012, 91:621-627.
50. Hayashi T., Shimoyama N., Mizuno T. Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjogren's syndrome in lupus-prone female NZB x NZWF(1) mice. Inflammation 2012, 35:638-646.
51. Hershey G.K. IL-13 receptors and signaling pathways: an evolving web. J.Allergy Clin. Immunol. 2003, 111:677-690.
52. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., Yamaguchi T., Nomura T., Ito H., Nakamura T., Sakaguchi N., Sakaguchi S. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J.Exp. Med. 2007, 204:2803-2812.
53. Hommes D.W., Mikhajlova T.L., Stoinov S., Stimac D., Vucelic B., Lonovics J., Zakuciova M., D'Haens G., Van A.G., Ba S., Lee S., Pearce T. Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease. Gut 2006, 55:1131-1137.
54. Ishimaru N., Arakaki R., Yoshida S., Yamada A., Noji S., Hayashi Y. Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy. J.Exp. Med. 2008, 205:2915-2927.
55. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
56. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. J.Clin. Investig. 2006, 116:1218-1222.
57. Jie G., Jiang Q., Rui Z., Yifei Y. Expression of interleukin-17 in autoimmune dacryoadenitis in MRL/lpr mice. Curr. Eye Res. 2010, 35:865-871.
58. Jones D.T., Monroy D., Ji Z., Atherton S.S., Pflugfelder S.C. Sjogren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Investig. Ophthalmol. Vis. Sci. 1994, 35:3493-3504.
59. Kagami S., Rizzo H.L., Lee J.J., Koguchi Y., Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J.Investig. Dermatol. 2010, 130:1373-1383.
60. Kang E.H., Lee Y.J., Hyon J.Y., Yun P.Y., Song Y.W. Salivary cytokine profiles in primary Sjogren's syndrome differ from those in non-Sjogren sicca in terms of TNF-alpha levels and Th-1/Th-2 ratios. Clin. Exp. Rheumatol. 2011, 29:970-976.
61. Katsifis G.E., Rekka S., Moutsopoulos N.M., Pillemer S., Wahl S.M. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am. J. Pathol. 2009, 175:1167-1177.
62. Katsiougiannis S., Tenta R., Skopouli F.N. Activation of AMP-activated protein kinase by adiponectin rescues salivary gland epithelial cells from spontaneous and interferon-gamma-induced apoptosis. Arthritis Rheum. 2010, 62:414-419.
63. Khandelwal P., Blanco-Mezquita T., Emami P., Lee H.S., Reyes N.J., Mathew R., Huang R., Saban D.R. Ocular mucosal CD11b+ and CD103+ mouse dendritic cells under normal conditions and in allergic immune responses. PLoS One 2013, 8(5):e64193.
64. Kikly K., Liu L., Na S., Sedgwick J.D. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 2006, 18:670-675.
65. Knop E., Knop N. The role of eye-associated lymphoid tissue in corneal immune protection. J.Anat. 2005, 206:271-285.
66. Koarada S., Haruta Y., Mitamura M., Morito F., Tada Y., Ohta A., Nagasawa K. Exvivo CD(+) T-cell cytokine expression from patients with Sjogren's syndrome following invitro stimulation to induce proliferation. Rheumatology (Oxford) 2006, 45:392-399.
67. Kohashi M., Ishimaru N., Arakaki R., Hayashi Y. Effective treatment with oral administration of rebamipide in a mouse model of Sjogren's syndrome. Arthritis Rheum. 2008, 58:389-400.
68. Konttinen Y.T., Kemppinen P., Koski H., Li T.F., Jumppanen M., Hietanen J., Santavirta S., Salo T., Larsson A., Hakala M., Sorsa T. T(H)1 cytokines are produced in labial salivary glands in Sjogren's syndrome, but also in healthy individuals. Scand. J. Rheumatol. 1999, 28:106-112.
69. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., Oukka M., Kuchroo V.K. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
70. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 2009, 27:485-517.
71. Korn T., Mitsdoerffer M., Croxford A.L., Awasthi A., Dardalhon V.A., Galileos G., Vollmar P., Stritesky G.L., Kaplan M.H., Waisman A., Kuchroo V.K., Oukka M. IL-6 controls Th17 immunity invivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18460-18465.
72. Korn T., Oukka M., Kuchroo V., Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin. Immunol. 2007, 19:362-371.
73. Kunert K.S., Tisdale A.S., Stern M.E., Smith J.A., Gipson I.K. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch. Ophthalmol. 2000, 118:1489-1496.
74. LaFrance M.W., Kehinde L.E., Fullard R.J. Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assay. Curr. Eye Res. 2008, 33:525-544.
75. Lam H., Blieden L., de Paiva C.S., Farley W.J., Stern M.E., Pflugfelder S.C. Tear cytokine profiles in dysfunctional tear syndrome. Am. J. Ophthalmol. 2008, 14:198-272.
76. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J.Exp. Med. 2005, 201:233-240.
77. Lee H.S., Chauhan S.K., Okanobo A., Nallasamy N., Dana R. Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. Cornea 2011, 30:1465-1472.
78. Lee M.H., Choi J.W., Jang W.R., Kim J.M., Kim J.H. Activation of eosinophils is more closely linked with Interleukin-5 and nitric oxide production than tumor necrosis factor-α and immunoglobulin E levels. Acta Haematol. 2013, 130(4):238-241.
79. Li Z., Burns A.R., Miller S.B., Smith C.W. CCL20, gammadelta T cells, and IL-22 in corneal epithelial healing. Faseb J. 2011, 25:2659-2668.
80. Lyakh L., Trinchieri G., Provezza L., Carra G., Gerosa F. Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol. Rev. 2008, 226:112-131.
81. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
82. Manoussakis M.N., Dimitriou I.D., Kapsogeorgou E.K., Xanthou G., Paikos S., Polihronis M., Moutsopoulos H.M. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjogren's syndrome. Arthritis Rheum. 1999, 42:229-239.
83. Marko C.K., Menon B.B., Chen G., Whitsett J.A., Clevers H., Gipson I.K. Spdef null mice lack conjunctival goblet cells and provide a model of dry eye. Am. J. Pathol. 2013, 183:35-48.
84. Massingale M.L., Li X., Vallabhajosyula M., Chen D., Wei Y., Asbell P.A. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea 2009, 28:1023-1027.
85. Mitsias D.I., Tzioufas A.G., Veiopoulou C., Zintzaras E., Tassios I.K., Kogopoulou O., Moutsopoulos H.M., Thyphronitis G. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin. Exp. Immunol. 2002, 128:562-568.
86. Moseley T.A., Haudenschild D.R., Rose L., Reddi A.H. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 2003, 14:155-174.
87. Mosmann T.R. Tlymphocyte subsets, cytokines, and effector functions. Ann. N. Y. Acad. Sci. 1992, 664:89-92.
88. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J.Immunol. 1986, 136:2348-2357.
89. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7:145-173.
90. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 1996, 17:138-146.
91. Mrugacz M., Kaczmarski M., Bakunowicz-Lazarczyk A., Zelazowska B., Wysocka J., Minarowska A. IL-8 and IFN-gamma in tear fluid of patients with cystic fibrosis. J.Interferon. Cytokine Res. 2006, 26:71-75.
92. Muhl H., Bachmann M., Pfeilschifter J. Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity. Cell. Microbiol. 2011, 13:340-348.
93. Nasonova V.A., Lukina G.V., Sigidin I. Neutralisation of interferon gamma - a new trend in therapy of rheumatoid arthritis. Ter. Arkh. 2008, 80:30-37.
94. Nguyen C.Q., Hu M.H., Li Y., Stewart C., Peck A.B. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice. Arthritis Rheum. 2008, 58:734-743.
95. Niederkorn J.Y., Stern M.E., Pflugfelder S.C., de Paiva C.S., Corrales R.M., Gao J., Siemasko K. Desiccating stress induces T cell-mediated Sjogren's syndrome-like lacrimal keratoconjunctivitis. J.Immunol. 2006, 176:3950-3957.
96. Nurieva R.I., Chung Y., Hwang D., Yang X.O., Kang H.S., Ma L., Wang Y.H., Watowich S.S., Jetten A.M., Tian Q., Dong C. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008, 29:138-149.
97. Nguyen C.Q., Peck A.B. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul. Surf. 2009, 7:11-27.
98. Ogawa N., Ping L., Zhenjun L., Takada Y., Sugai S. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren's syndrome. Arthritis Rheum. 2002, 46:2730-2741.
99. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. Adistinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
100. Peck A.B., Nguyen C.Q. Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjogren's syndrome. Scand. J. Immunol. 2012, 76:237-245.
101. Pelegrino F.S., Volpe E.A., Gandhi N.B., Li D.Q., Pflugfelder S.C., de Paiva C.S. Deletion of interferon-gamma delays onset and severity of dacryoadenitis in CD25KO mice. Arthritis Res. Ther. 2012, 14:R234.
102. Pertovaara M., Antonen J., Hurme M. Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome. Ann. Rheum. Dis. 2006, 65:666-670.
103. Pflugfelder S.C. Anti-inflammatory therapy of dry eye. Am. J. Ophthalmol. 2004, 137:337-342.
104. Pflugfelder S.C., de Paiva C.S., Villarreal A.L., Stern M.E. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea 2008, 27:64-69.
105. Pflugfelder S.C., Farley W., Luo L., Chen L.Z., de Paiva C.S., Olmos L.C., Li D.Q., Fini M.E. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am. J. Pathol. 2005, 166:61-71.
106. Pflugfelder S.C., Jones D., Ji Z., Afonso A., Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr. Eye Res. 1999, 19:201-211.
107. Pitcher J., de Paiva C.S., Pelegrino F., McClellan A., Raince J., Pangelinan S., Rahimy E., Farley W., Stern M., Li D., Pflugfelder S. Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal gland. Investig. Ophthalmol. Vis. Sci. 2011, 52:3221-3227.
108. Qiao D., Yang B.Y., Li L., Ma J.J., Zhang X.L., Lao S.H., Wu C.Y. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection. Scand. J. Immunol. 2011, 73:330-337.
109. Rahimy E., Pitcher J.D., Pangelinan S.B., Chen W., Farley J.W., Niederkorn J.Y., Stern M.E., Li D.-Q., Pflugfelder S.C., de Paiva C.S. Spontaneous autoimmune dacryoadenitis in aged CD25KO mice. Am. J. Pathol. Aug 2010, 177(2):744-753. (Epub 2010 Jun 21).
110. Riemens A., Stoyanova E., Rothova A., Kuiper J. Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. Mol. Vis. 2012, 18:797-802.
111. Ryan-Payseur B., Ali Z., Huang D., Chen C.Y., Yan L., Wang R.C., Collins W.E., Wang Y., Chen Z.W. Virus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease. J.Infect. Dis. 2011, 204:1450-1462.
112. Sadrai Z., Stevenson W., Okanobo A., Chen Y., Dohlman T.H., Hua J., Amparo F., Chauhan S.K., Dana R. PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease. Investig. Ophthalmol. Vis. Sci. 2012, 53:3584-3591.
113. Saito I., Terauchi K., Shimuta M., Nishiimura S., Yoshino K., Takeuchi T., Tsubota K., Miyasaka N. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. J.Clin. Lab. Anal. 1993, 7:180-187.
114. Sakai A., Sugawara Y., Kuroishi T., Sasano T., Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J.Immunol. 2008, 181:2898-2906.
115. Sanos S.L., Diefenbach A. Innate lymphoid cells: from border protection to the initiation of inflammatory diseases. Immunol. Cell. Biol. 2013, 91:215-224.
116. Schaumburg C.S., Siemasko K.F., de Paiva C.S., Pflugfelder M.E., Stern M.E. Ocular surface antigen presenting cells are necessary for activation of autoreactive T cells and development of autoimmune lacrimal keratoconjunctivtis. J.Immunol. 2011, 187:3653-3662.
117. Shao L.L., Zhang L., Hou Y., Yu S., Liu X.G., Huang X.Y., Sun Y.X., Tian T., He N., Ma D.X., Peng J., Hou M. Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome. PLoS One 2012, 7:e51339.
118. Sigidin Y.A., Loukina G.V., Skurkovich B., Skurkovich S. Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis. Scand. J. Rheumatol. 2001, 30:203-207.
119. Skurkovich B., Skurkovich S. Autoimmune diseases are connected with disturbances in cytokine synthesis, and therapy with IFN-gamma blockers is their main pathogenetic treatment. Ann. N. Y. Acad. Sci. 2007, 1109:167-177.
120. Skurkovich S., Korotky N.G., Sharova N.M., Skurkovich B. Treatment of alopecia areata with anti-interferon-gamma antibodies. J.Invetig. Dermatol. Symp. Proc. 2005, 10:283-284.
121. Skurkovich S., Skurkovich B., Bellanti J.A. Aunifying model of the immunoregulatory role of the interferon system: can interferon produce disease in humans?. Clin. Immunol. Immunopathol. 1987, 43:362-373.
122. Skurkovich S., Skurkovich B., Kelly J. Anticytokine therapy, particularly anti-IFN-gamma, in Th1-mediated autoimmune diseases. Expert Rev. Clin. Immunol. 2005, 1:11-25.
123. Solomon A., Dursun D., Liu Z., Xie Y., Macri A., Pflugfelder S.C. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Investig. Ophthalmol. Vis. Sci. 2001, 42:2283-2292.
124. Solomon A., Rosenblatt M., Monroy D., Ji Z., Pflugfelder S.C., Tseng S.C. Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br. J. Ophthalmol. 2001, 85:444-449.
125. Stern M.E., Gao J., Schwalb T.A., Ngo M., Tieu D.D., Chan C.C., Reis B.L., Whitcup S.M., Thompson D., Smith J.A. Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye. Investig. Ophthalmol. Vis. Sci. 2002, 43:2609-2614.
126. Stern M.E., Schaumburg C.S., Pflugfelder S.C. Dry eye as a mucosal autoimmune disease. Int. Rev. Immunol. 2013, 32:19-41.
127. Stockinger B., Veldhoen M., Martin B. Th17 T cells: linking innate and adaptive immunity. Semin. Immunol. 2007, 19:353-361.
128. Strong B., Farley W., Stern M.E., Pflugfelder S.C. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea 2005, 24:80-85.
129. Szodoray P., Gal I., Barath S., Aleksza M., Horvath I.F., Gergely P., Szegedi G., Nakken B., Zeher M. Immunological alterations in newly diagnosed primary Sjogren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines. Scand. J. Rheumatol. 2008, 37:205-212.
130. Tian T., Yu S., Ma D. Th22 and related cytokines in inflammatory and autoimmune diseases. Expert Opin. Ther. Targets 2013, 17:113-125.
131. Tomlinson A., Khanal S., Ramaesh K., Diaper C., McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Investig. Ophthalmol. Vis. Sci. 2006, 47:4309-4315.
132. Tsubota K., Fukagawa K., Fujihara T., Shimmura S., Saito I., Saito K., Takeuchi T. Regulation of human leukocyte antigen expression in human conjunctival epithelium. Investig. Ophthalmol. Vis. Sci. 1999, 40:28-34.
133. Tsunawaki S., Nakamura S., Ohyama Y., Sasaki M., Ikebe-Hiroki A., Hiraki A., Kadena T., Kawamura E., Kumamaru W., Shinohara M., Shirasuna K. Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjogren's syndrome. J.Rheumatol. 2002, 29:1884-1896.
134. Turner K., Pflugfelder S.C., Ji Z., Feuer W.J., Stern M., Reis B.L. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea 2000, 19:492-496.
135. Turpie B., Yoshimura T., Gulati A., Rios J.D., Dartt D.A., Masli S. Sjogren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice. Am. J. Pathol. 2009, 175:1136-1147.
136. Ueta M., Kinoshita S. Ocular surface inflammation is regulated by innate immunity. Prog. Retin. Eye Res. 2012, 31:551-575.
137. van Woerkom J.M., Kruize A.A., Wenting-van Wijk M.J., Knol E., Bihari I.C., Jacobs J.W., Bijlsma J.W., Lafeber F.P., van Roon J.A. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjogren's syndrome compared with non-Sjogren's sicca syndrome. Ann. Rheum. Dis. 2005, 64:1474-1479.
138. Viau S., Pasquis B., Maire M.A., Fourgeux C., Gregoire S., Acar N., Bretillon L., Creuzot-Garcher C.P., Joffre C. No consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eye. Graefe's Arch. Clin. Exp. Ophthalmol. 2011, 249:547-557.
139. Wang C., Kang S.G., Lee J., Sun Z., Kim C.H. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol. 2009, 2:173-183.
140. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007, 25:821-852.
141. Wilson M.S., Ramalingam T.R., Rivollier A., Shenderov K., Mentink-Kane M.M., Madala S.K., Cheever A.W., Artis D., Kelsall B.L., Wynn T.A. Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity. Gastroenterology 2011, 140:254-264.
142. Wolff M.J., Leung J.M., Davenport M., Poles M.A., Cho I., Loke P. TH17, TH22 and Treg cells are enriched in the healthy human cecum. PLoS One 2012, 7:e41373.
143. Yoon K.C., de Paiva C.S., Qi H., Chen Z., Farley W.J., Li D.Q., Pflugfelder S.C. Expression of th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress. Investig. Ophthalmol. Vis. Sci. 2007, 48:2561-2569.
144. Yoon K.C., Park C.S., You I.C., Choi H.J., Lee K.H., Im S.K., Park H.Y., Pflugfelder S.C. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Investig. Ophthalmol. Vis. Sci. 2010, 51:643-650.
145. Zhang N., Pan H.F., Ye D.Q. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol. Cell. Biochem. 2011, 353:41-46.
146. Zhang X., Chen W., de Paiva C.S., Corrales R.M., Volpe E.A., McClellan A.J., Farley W.J., Li D.Q., Pflugfelder S.C. Interferon-{gamma} exacerbates dry eye induced apoptosis in conjunctiva via dual apoptotic pathways. Investig. Ophthalmol. Vis. Sci. 2011, 52:6279-6285.
147. Zhang X., Chen W., de Paiva C.S., Volpe E.A., Gandhi N.B., Farley W.J., Li D.Q., Niederkorn J.Y., Stern M.E., Pflugfelder S.C. Desiccating stress induces CD4(+) T-cell-mediated Sjogren's syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-gamma. Am. J. Pathol. 2011, 179:1807-1814.
148. Zhang X., Volpe E.A., Gandhi N.B., Schaumburg C.S., Siemasko K.F., Pangelinan S.B., Kelly S.D., Hayday A.C., Li D.Q., Stern M.E., Niederkorn J.Y., Pflugfelder S.C., de Paiva C.S. NK cells promote Th-17 mediated corneal barrier disruption in dry eye. PLoS One 2012, 7:e36822.
149. + cells regulate the T helper-17 response in an experimental murine model of Sjögren syndrome. Mucosal Immunol. 2013, (in press).
150. Zheng X., Bian F., Ma P., de Paiva C.S., Stern M., Pflugfelder S.C., Li D.Q. Induction of Th17 differentiation by corneal epithelial-derived cytokines. J.Cell. Physiol. 2009, 222(1):95-102.
151. Zheng X., de Paiva C.S., Li D.Q., Farley W.J., Pflugfelder S.C. Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway. Investig. Ophthalmol. Vis. Sci. 2010, 51:3083-3091.
152. Zhu J., Paul W.E. CD4 T cells: fates, functions, and faults. Blood 2008, 112:1557-1569.
153. + T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol. Rev. 2010, 238:247-262.